This report was first published by Endpoints News. To see the original version, click here
AstraZeneca has added more details on how it will use its $15 billion budget to expand in China — and the UK pharma is betting on cell therapy.
AstraZeneca said Thursday it will be building a cell therapy research center and a separate factory in Shanghai, where it is headquartered in China.
您已阅读12%（381字），剩余88%（2754字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。